[(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate

C27H36Br2O7 — CID 124906320

About [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate

[(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate (PubChem CID 124906320) has the molecular formula C27H36Br2O7 and a molecular weight of 632.39 g/mol. Its IUPAC name is [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate.

Molecular Properties

• Compound Name: [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate
• PubChem CID: 124906320
• Molecular Formula: C27H36Br2O7
• Molecular Weight: 632.39 g/mol
• Exact Mass: 630.08
• IUPAC Name: [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate
• SMILES: C[C@]12CC[C@H](OC(=O)CBr)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@H](C3=CC(=O)OC3)[C@@H](OC(=O)CBr)C[C@]12O
• InChI: InChI=1S/C27H36Br2O7/c1-25-7-5-17(35-22(31)12-28)10-16(25)3-4-19-18(25)6-8-26(2)24(15-9-21(30)34-14-15)20(11-27(19,26)33)36-23(32)13-29/h9,16-20,24,33H,3-8,10-14H2,1-2H3/t16-,17-,18-,19+,20-,24+,25-,26+,27-/m0/s1
• InChIKey: JBKZFONWFOPSFB-VNDDKXHLSA-N
• XLogP: 4.47
• TPSA: 99.13 Ų
• H-Bond Donors: 1
• H-Bond Acceptors: 7
• Rotatable Bonds: 5
• Heavy Atoms: 36
• Complexity: —

Lipinski Rule of Five

1 violation

Rule	Value
MW ≤ 500	632.39
LogP ≤ 5	4.47
H-Bond Donors ≤ 5	1
H-Bond Acceptors ≤ 10	7

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate?

The IUPAC name of [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate (CID 124906320) is [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate.

What is the SMILES notation for [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate?

The canonical SMILES for [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate is C[C@]12CC[C@H](OC(=O)CBr)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@H](C3=CC(=O)OC3)[C@@H](OC(=O)CBr)C[C@]12O.

What is the InChIKey of [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate?

The InChIKey is JBKZFONWFOPSFB-VNDDKXHLSA-N. The full InChI is InChI=1S/C27H36Br2O7/c1-25-7-5-17(35-22(31)12-28)10-16(25)3-4-19-18(25)6-8-26(2)24(15-9-21(30)34-14-15)20(11-27(19,26)33)36-23(32)13-29/h9,16-20,24,33H,3-8,10-14H2,1-2H3/t16-,17-,18-,19+,20-,24+,25-,26+,27-/m0/s1.

What are the key properties of [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate?

[(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate has a molecular weight of 632.39 g/mol, XLogP of 4.47, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.

Where does this data come from?

All data for [(3S,5S,8R,9S,10S,13R,14S,16S,17S)-16-(2-bromoacetyl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] 2-bromoacetate is sourced from PubChem (CID 124906320), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).